DA93 - Small Intestine Motility Disorders: Complete Coding Guide

1. Introduction

Small intestine motility disorders represent a complex group of conditions characterized by abnormalities in the contractile function of the small intestine, significantly affecting the digestive system's capacity to adequately propel food content. These disorders result from weak, disorganized, or uncoordinated contractions, compromising normal digestive processes and potentially leading to serious complications such as intestinal distension and bacterial overgrowth.

Adequate intestinal motility is fundamental for digestion, nutrient absorption, and waste elimination. When this system fails, patients experience debilitating symptoms that drastically affect their quality of life. Small intestine motility disorders can occur as primary conditions or secondary to other systemic diseases, and are frequently underdiagnosed due to the complexity of their clinical presentation.

The exact prevalence of these disorders is difficult to determine, as many cases remain undiagnosed or are confused with other gastrointestinal conditions. However, specialists recognize that these disorders represent an important cause of chronic digestive symptoms, especially in patients with neurological, endocrine, or autoimmune comorbidities.

Correct coding of these disorders is critical for multiple aspects of clinical care. First, it allows appropriate recognition of the condition in medical records, facilitating longitudinal follow-up. Second, it aids in appropriate allocation of resources for specialized diagnostic investigation. Third, it contributes to epidemiological studies that may improve our understanding of these conditions. Finally, it ensures that patients receive adequate coverage for specific and often costly treatments necessary for the management of these complex disorders.

2. Correct ICD-11 Code

Code: DA93

Description: Disorders of small intestine motility

Parent category: Diseases of the small intestine

Official definition: Disorders of small intestine motility due to abnormal contractions, such as weak contractions and disorganized (uncoordinated) contractions. Loss of the ability to coordinate motor activity may cause a variety of disorders, including small intestine distension and bacterial overgrowth.

This specific ICD-11 code was developed to precisely capture conditions where the motor function of the small intestine is compromised, regardless of the underlying etiology. Code DA93 encompasses situations where the central pathophysiology is contractile dysfunction, whether due to muscle weakness, neural incoordination, or alterations in the enteric nervous system.

It is important to understand that this code focuses on functional dysfunction of motility, not on mechanical obstructions or structural abnormalities. The emphasis is on the impaired ability of the small intestine to perform its normal peristaltic contractions in a coordinated and effective manner. This distinction is fundamental for appropriate coding and differentiation from other intestinal conditions.

Code DA93 allows healthcare professionals to appropriately document cases where imaging studies may not show anatomical obstruction, but functional studies demonstrate abnormal motility. This diagnostic precision is essential to guide appropriate therapeutic strategies, which differ significantly from the treatment of mechanical obstructions or other intestinal pathologies.

3. When to Use This Code

The code DA93 should be applied in specific clinical scenarios where evidence clearly points to small intestine motility dysfunction. Below are detailed practical situations:

Scenario 1: Chronic Intestinal Pseudo-obstruction A patient presents with recurrent episodes of severe abdominal distension, nausea, vomiting, and colicky abdominal pain. Imaging studies reveal small intestine dilation without evidence of mechanical obstruction. Intestinal transit studies demonstrate prolonged transit time through the small intestine. Intestinal manometry, when available, shows low-amplitude contractions or uncoordinated patterns. This is a classic case for use of code DA93.

Scenario 2: Post-Surgical Dismotility A patient who underwent complex abdominal surgery develops persistent symptoms of intestinal stasis after the immediate postoperative period. Presents with food intolerance, progressive distension after eating, and radiological evidence of delayed intestinal transit. No adhesions or mechanical obstructions are identified. Intestinal motility is compromised, characterizing a functional disorder appropriate for DA93.

Scenario 3: Autonomic Neuropathy with Dismotility A patient with a systemic disease known to affect the autonomic nervous system presents with progressive gastrointestinal symptoms. Complaints include early satiety, postprandial distension, chronic nausea, and alterations in bowel habits. Investigation demonstrates delayed gastric emptying and significantly prolonged small intestine transit, without anatomical obstruction. Code DA93 adequately captures the intestinal dismotility present.

Scenario 4: Bacterial Overgrowth Secondary to Stasis A patient with a history of chronic diarrhea, abdominal distension, weight loss, and nutritional deficiencies. Breath testing confirms small intestine bacterial overgrowth. Further investigation reveals abnormal intestinal motility as the underlying cause of stasis that allowed excessive bacterial proliferation. DA93 is appropriate when dismotility is the primary problem.

Scenario 5: Myopathic Dismotility A patient presents with symptoms suggestive of motility disorder with evidence of small intestine smooth muscle involvement. There may be a family history of similar conditions or histological evidence of muscular alterations. Functional studies demonstrate weak and ineffective small intestine contractions. This myopathic pattern of dismotility justifies the use of code DA93.

Scenario 6: Idiopathic Motor Dysfunction A patient with chronic symptoms of intestinal dismotility where extensive investigation excludes known secondary causes. Studies objectively demonstrate abnormal small intestine motility, but no specific etiology is identified. Code DA93 remains appropriate for documenting the functional disorder present, even when the underlying cause is not completely elucidated.

4. When NOT to Use This Code

It is fundamental to recognize situations where code DA93 is not appropriate, avoiding diagnostic confusion and ensuring accurate coding:

Mechanical Obstructions: When there is physical blockage of the intestinal lumen by adhesions, tumors, strangulated hernias, volvulus, or foreign bodies, the appropriate code is DA91 (Obstruction of the small intestine). The crucial distinction is the presence of an anatomical barrier to intestinal flow versus contractile dysfunction.

Structural Congenital Anomalies: Malformations of small intestine development, such as congenital stenoses, duplications, or other structural anomalies present since birth, should be coded as DA90 (Non-structural anomalies of small intestine development), not DA93. Even though these conditions may secondarily affect motility, the primary code reflects the structural anomaly.

Acquired Anatomical Changes: When the small intestine undergoes acquired structural changes such as post-inflammatory stenoses, fistulas, or post-radiation changes, the code DA92 (Other acquired anatomical changes of the small intestine) is more appropriate. Again, although these conditions may impact motility, coding should reflect the primary anatomical change.

Primary Functional Conditions of the Colon: When symptoms are predominantly related to large intestine dysfunction, such as irritable bowel syndrome with predominant colonic involvement, specific codes for functional disorders of the colon should be used.

Gastritis or Gastroduodenal Disease: Symptoms related to the stomach or proximal duodenum should be coded with specific codes for these anatomical regions, not with DA93, which is specific to the small intestine.

Primary Malabsorption: When the primary condition is an absorption disorder (such as celiac disease, pancreatic insufficiency, or enzymatic defects) without evidence of significant dysmotility, specific codes for malabsorption syndromes should be used.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The first crucial step is to confirm that the patient genuinely presents with a small intestine motility disorder. This requires:

Compatible Clinical Presentation: Document symptoms suggestive of dysmotility such as abdominal distension, nausea, vomiting, colicky abdominal pain, early satiety, progressive food intolerance, and alterations in bowel habits. The chronology and pattern of symptoms must be carefully recorded.

Exclusion of Mechanical Obstruction: Perform appropriate imaging studies (plain radiography, computed tomography, or magnetic resonance imaging of the abdomen) to exclude anatomical obstructive causes. The absence of a transition point, obstructive masses, or other mechanical lesions is essential.

Motility Studies: When available, functional studies provide objective evidence. Intestinal transit studies with radiopaque markers or scintigraphy can demonstrate slowed transit. Intestinal manometry, although available only in specialized centers, can document abnormal contraction patterns. These objective tests significantly strengthen the diagnosis.

Evaluation of Complications: Investigate evidence of bacterial overgrowth through breath tests or jejunal aspirate culture. Assess nutritional status and presence of vitamin deficiencies that may result from chronic dysmotility.

Step 2: Verify Specifiers

After confirming the diagnosis, consider specific characteristics that may influence management:

Severity: Assess functional impact. Patients with mild and intermittent symptoms differ from those with severe chronic pseudo-obstruction requiring parenteral nutrition. Documenting severity aids in therapeutic planning.

Duration: Distinguish between acute presentations (potentially reversible) and chronic ones (generally requiring long-term management). Chronicity has important prognostic implications.

Pattern: Identify whether there are acute episodes superimposed on chronic condition or constant progressive symptoms. Some patients have intermittent exacerbations while others experience gradual deterioration.

Complications Present: Document presence of bacterial overgrowth, nutritional deficiencies, dependence on enteral or parenteral nutrition, and other complications that affect prognosis and treatment.

Step 3: Differentiate from Other Codes

DA90 vs. DA93: DA90 is for developmental anomalies present since birth, whereas DA93 is for functional motility disorders. The key difference is temporal (congenital vs. acquired or functional) and nature (structural vs. functional). If there is congenital anatomical malformation, use DA90; if there is contractile dysfunction without congenital structural anomaly, use DA93.

DA91 vs. DA93: DA91 requires evidence of mechanical obstruction with identifiable transition point and anatomical cause of blockage. DA93 is used when there is no true mechanical obstruction, but rather failure of propulsion due to contractile dysfunction. The key difference is presence versus absence of physical barrier to intestinal flow.

DA92 vs. DA93: DA92 is for acquired anatomical changes such as strictures, fistulas, or structural changes post-inflammatory or post-radiation. DA93 is for motor dysfunction without significant structural change. The key difference is whether there is identifiable anatomical change (DA92) or primary functional dysfunction (DA93).

Step 4: Required Documentation

For appropriate coding with DA93, the medical record must include:

Mandatory Documentation Checklist:

• Detailed description of symptoms and their chronology
• Results of imaging studies excluding mechanical obstruction
• Results of transit or motility studies, when performed
• Evidence of complications such as bacterial overgrowth
• Nutritional assessment and identified deficiencies
• Treatments attempted and their responses
• Functional impact on patient's quality of life
• Secondary causes investigated and their results

Adequate Record: The documentation must clearly establish that the primary condition is intestinal motility dysfunction, not a secondary consequence of another condition more appropriately coded otherwise. If dysmotility is secondary to a systemic disease, both codes may be necessary, but the relationship must be clear.

6. Complete Practical Example

Clinical Case

Initial Presentation: A 42-year-old patient presents to gastroenterology consultation with a six-month history of progressive abdominal distension, frequent nausea, occasional vomiting, and diffuse cramping abdominal pain. Reports early satiety, able to ingest only small food portions. Lost 8 kilograms during this period. Denies fever, gastrointestinal bleeding, or history of previous abdominal surgeries. Previous medical history includes type 1 diabetes mellitus diagnosed 15 years ago, with irregular glycemic control.

Evaluation Performed: Physical examination reveals distended abdomen, tympanic to percussion, with diminished bowel sounds. No palpable masses or signs of peritoneal irritation. Laboratory tests show mild anemia, hypoalbuminemia, and vitamin B12 deficiency. Abdominal computed tomography demonstrates diffuse dilation of small bowel loops without transition point, masses, or other obstructive lesions. Upper gastrointestinal endoscopy normal through second portion of duodenum.

Small bowel transit study with radiopaque markers shows significant marker retention in the small intestine after 6 hours, with markedly prolonged total transit time. Hydrogen breath test positive for small intestinal bacterial overgrowth. Evaluation of diabetic autonomic neuropathy confirms autonomic nervous system involvement.

Diagnostic Reasoning: The clinical presentation of distension, nausea, vomiting, and food intolerance, combined with radiological evidence of intestinal dilation without mechanical obstruction, strongly suggests motility disorder. The prolonged intestinal transit time objectively documents dysmotility. The presence of long-standing diabetes mellitus with autonomic neuropathy provides etiological context, as diabetic neuropathy frequently affects the enteric nervous system, resulting in gastrointestinal dysmotility.

The bacterial overgrowth identified is a common complication of intestinal stasis caused by inadequate motility. Weight loss and nutritional deficiencies reflect malabsorption secondary to both dysmotility and bacterial overgrowth. There is no evidence of mechanical obstruction, congenital structural anomaly, or acquired anatomical alteration that would justify alternative codes.

Coding Justification: This case exemplifies perfectly the application of code DA93. The central problem is dysfunction of small bowel motility, manifested by inadequate contractions resulting in stasis, dilation, and secondary complications. Although an underlying cause exists (diabetic neuropathy), code DA93 appropriately captures the intestinal disorder present.

Step-by-Step Coding

Criteria Analysis:

• Symptoms compatible with dysmotility: Present (distension, nausea, vomiting, food intolerance)
• Exclusion of mechanical obstruction: Confirmed by computed tomography without evidence of obstructive lesion
• Objective evidence of dysmotility: Present (prolonged transit study)
• Typical complications: Present (bacterial overgrowth, nutritional deficiencies)

Code Selected: DA93 - Disorders of small bowel motility

Complete Justification: Code DA93 is appropriate because the patient presents with documented small bowel motility dysfunction without mechanical obstruction or structural anomaly. Dysmotility is the primary problem affecting the small bowel, resulting in significant clinical symptoms and measurable complications.

Complementary Codes:

• Code for type 1 diabetes mellitus with neurological complications (to document underlying etiology)
• Code for small intestinal bacterial overgrowth (to document complication)
• Codes for specific nutritional deficiencies identified (B12, protein)

This multiple coding approach completely captures the clinical picture: the underlying systemic condition (diabetes with neuropathy), the resulting intestinal disorder (dysmotility - DA93), and its complications (bacterial overgrowth, nutritional deficiencies).

7. Related Codes and Differentiation

Within the Same Category

DA90: Non-structural anomalies of small intestine development

When to use DA90: This code is appropriate for congenital malformations of the small intestine present from birth, such as atresias, congenital stenoses, intestinal duplications, or other developmental anomalies. The condition must be structural and originate during fetal development.

When to use DA93: Use DA93 when the problem is functional (contractile dysfunction) and not a congenital structural malformation. Even if dysmotility is long-standing, if there is no structural developmental anomaly, DA93 is appropriate.

Main difference: DA90 is for congenital structural defects; DA93 is for functional motor dysfunction, which may be congenital or acquired, but does not involve anatomical developmental malformation.

DA91: Obstruction of the small intestine

When to use DA91: This code should be used when there is true mechanical blockage of the intestinal lumen. Causes include adhesions, strangulated hernias, tumors, volvulus, intussusception, or foreign bodies. Imaging studies typically show a transition point with proximal dilation and distal decompression.

When to use DA93: Use DA93 when there is no true mechanical obstruction, but rather failure of intestinal propulsion due to contractile dysfunction. Dilation may be present, but without a defined transition point or identifiable obstructive cause.

Main difference: DA91 requires a physical barrier to intestinal flow; DA93 is dysfunction of contractile capacity without mechanical obstruction. This is one of the most important distinctions in clinical practice, as therapeutic approaches differ radically.

DA92: Other acquired anatomical alterations of the small intestine

When to use DA92: Appropriate for acquired structural changes of the small intestine, such as post-inflammatory stenoses (Crohn's disease), post-radiation actinosis stenoses, intestinal fistulas, or other anatomical alterations that develop after birth but are structural in nature.

When to use DA93: Use DA93 when there is no significant structural alteration, but rather dysfunction of motility. Even if dysmotility is acquired (post-surgical, for example), if there is no structural anatomical change, DA93 is more appropriate.

Main difference: DA92 is for identifiable acquired structural alterations; DA93 is for functional dysfunction without significant structural alteration. The distinction may be subtle when scarring or fibrosis affects motility, but generally the presence of stenosis or other defined anatomical alteration favors DA92.

Differential Diagnoses

Irritable Bowel Syndrome: Although it may involve alterations in motility, irritable bowel syndrome is typically classified as a functional intestinal disorder with specific diagnostic criteria and generally does not cause significant intestinal dilation or bacterial overgrowth. When there is objective evidence of severe small intestine dysmotility, DA93 is more appropriate.

Gastroparesis: When delayed emptying is predominantly gastric, specific codes for gastroparesis are more appropriate. DA93 should be reserved for when the small intestine is primarily affected, although both conditions may coexist.

Celiac Disease: Although it may cause gastrointestinal symptoms and malabsorption, celiac disease has a specific code and different pathophysiology. If there is severe secondary dysmotility, both codes may be appropriate.

Chronic Mesenteric Ischemia: May cause abdominal symptoms, but involves vascular compromise with distinct clinical features (postprandial pain, "fear of eating"). It has specific coding different from DA93.

8. Differences with ICD-10

Equivalent ICD-10 Code: In ICD-10, intestinal motility disorders were frequently coded under K59.8 (Other specified functional disorders of the intestine) or K59.9 (Functional disorder of the intestine, unspecified). There was no specific code dedicated exclusively to small intestine motility disorders.

Main Changes in ICD-11: ICD-11 introduces greater specificity with code DA93, allowing clear differentiation between small intestine motility disorders versus other functional intestinal disorders. This specificity represents a significant advance in diagnostic classification.

The hierarchical structure of ICD-11 also allows better organization, with DA93 clearly positioned within diseases of the small intestine, separated from colonic or general functional disorders. This organization facilitates navigation and selection of the appropriate code.

Additionally, ICD-11 provides more detailed definitions and guidance on when to use each code, reducing ambiguity. The definition of DA93 specifically mentions abnormal contractions, distension, and bacterial overgrowth, providing clarity on the scope of the code.

Practical Impact: For healthcare professionals, the transition to DA93 enables more precise documentation of small intestine motility disorders. This facilitates epidemiological studies, improves outcome tracking, and may influence decisions regarding coverage of specific treatments.

For researchers, the increased specificity allows more accurate identification of patient cohorts for clinical studies. For health administrators, it provides more refined data on prevalence and resource utilization for these specific conditions.

The change also reflects evolution in medical understanding of these disorders, recognizing them as distinct entities deserving of specific classification, not merely as "other functional disorders." This recognition may contribute to greater clinical attention and research into these frequently challenging conditions.

9. Frequently Asked Questions

1. How is the diagnosis of small bowel motility disorders made?

The diagnosis is established through a combination of clinical evaluation and objective tests. Clinically, the patient presents with suggestive symptoms such as abdominal distension, nausea, vomiting, abdominal pain, and food intolerance. Imaging studies (computed tomography or magnetic resonance imaging) are essential to exclude mechanical obstruction, typically showing intestinal dilation without a transition point. Intestinal transit studies using radiopaque markers or scintigraphy can objectively document delayed transit. In specialized centers, intestinal manometry can characterize abnormal contraction patterns. Tests for bacterial overgrowth (hydrogen breath test or jejunal aspirate culture) help identify complications. Nutritional assessment documents deficiencies resulting from dysmotility. Diagnosis is often challenging, requiring high clinical suspicion and systematic investigation.

2. Is treatment available in public health systems?

Treatment availability varies according to each health system's infrastructure. Basic treatments such as dietary modifications, prokinetic medications, and antibiotics for bacterial overgrowth are generally available in most public systems. Nutritional support with supplements or special formulas is also frequently accessible. However, more specialized treatments such as home parenteral nutrition, newer prokinetic medications, or procedures such as intestinal electrical stimulation may have limited availability or require special approvals. Some systems offer access through specialized centers for gastrointestinal motility disorders. Coverage for specialized diagnostic tests such as intestinal manometry also varies. Patients should consult with their healthcare providers about options available in their specific context.

3. How long does treatment last?

The duration of treatment depends on the underlying etiology and severity of the disorder. Cases secondary to reversible conditions (such as after surgery or infection) may improve within weeks to months with appropriate treatment. However, many small bowel motility disorders are chronic conditions requiring long-term management, often for years or indefinitely. Treatment is generally aimed at symptom control, prevention of complications, and maintenance of nutritional status, rather than definitive cure. Patients with chronic intestinal pseudo-obstruction may require lifelong nutritional support. Regular follow-up with a gastroenterologist or motility specialist is typically necessary for therapeutic adjustments. Some patients experience periods of improvement alternating with exacerbations, requiring temporary intensification of treatment. The approach is individualized based on clinical response and disease progression.

4. Can this code be used in medical certificates?

Yes, the code DA93 can and should be used in medical certificates when appropriate. Proper documentation in certificates is important to justify work absences, need for workplace modifications, or requests for disability benefits. Small bowel motility disorders can cause debilitating symptoms that significantly affect functional capacity. The certificate should include not only the code, but also a description of the symptoms and resulting functional limitations. For prolonged periods of absence, supporting documentation such as test results and specialist reports strengthens the justification. It is important that the physician clearly describes how the condition impacts daily activities and work capacity. In severe cases requiring parenteral nutrition or frequent hospitalizations, detailed documentation is especially critical for disability benefit processes.

5. Are small bowel motility disorders hereditary?

Some small bowel motility disorders have a hereditary component, while others are acquired. Familial forms of chronic intestinal pseudo-obstruction have been described, some with identified inheritance patterns and specific genetic mutations affecting intestinal muscle or neural proteins. Systemic conditions with genetic predisposition (such as some connective tissue diseases or muscular dystrophies) may include intestinal dysmotility as a manifestation. However, many cases are sporadic without clear family history. Disorders secondary to diabetes, scleroderma, or other acquired conditions are not directly hereditary, although the underlying condition may have a genetic component. When there is a family history of gastrointestinal dysmotility, genetic evaluation may be considered, especially if onset is in early age or associated with other systemic manifestations. Genetic counseling may be appropriate in familial cases to discuss recurrence risks.

6. What are the most serious complications of these disorders?

Complications can be significant and occasionally fatal. Small intestinal bacterial overgrowth results in malabsorption, diarrhea, vitamin deficiencies (especially B12), and progressive malnutrition. Severe intestinal distension can cause intense pain and, rarely, intestinal ischemia from vascular compromise. Severe malnutrition may require total parenteral nutrition, which carries its own risks including catheter infections, venous thrombosis, and associated liver disease. Recurrent vomiting can lead to electrolyte imbalances, dehydration, and pulmonary aspiration. Severe weight loss and nutritional deficiencies affect multiple organ systems. Quality of life is frequently profoundly impacted, with severe dietary restrictions, chronic pain, and social isolation. In more severe cases, there may be need for surgeries such as decompressive gastrostomy or jejunostomy for feeding. Rarely, intestinal transplantation is considered in refractory cases with parenteral nutrition dependence and associated complications.

7. Can children develop small bowel motility disorders?

Yes, children can be affected, although it is less common than in adults. Congenital or early-onset forms include primary chronic intestinal pseudo-obstruction, which can manifest from the neonatal period or early childhood. These pediatric forms often have a genetic basis and can be particularly challenging to diagnose and manage. Children with systemic conditions such as muscular dystrophies, mitochondrial diseases, or neuropathies may develop intestinal dysmotility as part of the clinical picture. Diagnosis in children requires high clinical suspicion, as symptoms may be nonspecific or erroneously attributed to other causes. Inadequate growth, recurrent vomiting, abdominal distension, and feeding difficulties should alert to the possibility of dysmotility. Pediatric management requires a multidisciplinary approach including pediatric gastroenterologist, nutritionist, and frequently other specialists. The impact on development and growth makes early diagnosis and treatment particularly important.

8. Is there a definitive cure for these disorders?

The possibility of cure depends on the underlying etiology. Disorders secondary to treatable conditions (such as infections, metabolic disorders, or medication use) may improve significantly or resolve with treatment of the underlying cause. However, primary forms of dysmotility, especially those with genetic or degenerative basis, generally have no definitive cure. Treatment focuses on symptom management, nutritional optimization, and prevention of complications. Therapeutic advances include new prokinetic agents, electrical stimulation therapies, and in selected severe cases, intestinal transplantation, although the latter is reserved for exceptional situations due to complexity and risks. Research in regenerative therapies and tissue engineering offers future hope, but remains experimental. For most patients, the realistic goal is adequate symptom control and maintenance of the best possible quality of life, rather than complete cure. Continued specialized follow-up is essential to optimize long-term outcomes.

---

Conclusion:

The ICD-11 code DA93 provides an essential tool for accurate classification of small bowel motility disorders, complex conditions that significantly affect patients' quality of life. Proper understanding of when to use this code, how to differentiate it from related conditions, and how to appropriately document the diagnosis is fundamental for healthcare professionals involved in the care of these patients. Accurate coding not only facilitates communication between professionals and institutions, but also contributes to better epidemiological understanding, appropriate resource allocation, and ultimately better outcomes for patients living with these challenging disorders.

External References

This article was prepared based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Small intestine motility disorders
2. 🔬 PubMed Research on Small intestine motility disorders
3. 🌍 WHO Health Topics
4. 📊 Clinical Evidence: Small intestine motility disorders
5. 📋 Ministry of Health - Brazil
6. 📊 Cochrane Systematic Reviews

References verified on 2026-02-03